Company Filing History:
5 out of 5 
1 out of 1 
1 out of 10 
Years Active: 1999-2007
Title: Abraham Grossman: Innovator in Agglomeration Protein Detection
Introduction
Abraham Grossman is a notable inventor based in Pleasantville, NY (US), recognized for his contributions to the field of molecular biology and diagnostics. With a total of seven patents to his name, Grossman has made significant advancements in the detection and analysis of agglomeration proteins.
Latest Patents
Among his latest patents, Grossman has developed compositions and methods for binding agglomeration proteins. These amplibody compositions are designed to interact with agglomeration proteins, comprising one or more DNA or RNA molecules that have an affinity for at least one agglomeration protein. The nucleic acid component can be a naturally or non-naturally occurring molecule with twenty or more ribonucleotide bases. For RNA, at least one nucleotide sequence portion has an affinity to a consensus sequence present in the agglomeration RNA-binding protein. The methods disclosed aim to detect the presence of one or more agglomeration proteins in a sample matrix using these innovative amplibody compositions.
Another significant patent focuses on compositions, methods, kits, and apparatus for determining the presence or absence of target molecules. This invention is directed towards identifying and detecting target analytes, which has utility in medical diagnosis and the analysis of various chemical compounds in specimens. The design of test kits and apparatus for implementing these methods further enhances their practical application.
Career Highlights
Throughout his career, Grossman has worked with several companies, including Invitro Diagnostics, Inc. and Q-RNA, Inc. His work in these organizations has contributed to the development of advanced diagnostic tools and methodologies.
Collaborations
Grossman has collaborated with notable individuals in his field, including Alexander Munishkin and Valentine M. Kryukov. These partnerships have likely fostered innovation and the exchange of ideas, further enhancing the impact of his work.
Conclusion
Abraham Grossman stands out as a significant figure in the realm of molecular diagnostics, with a focus on agglomeration proteins. His innovative patents and collaborations reflect his commitment to advancing medical technology and improving diagnostic methods.